Dr. Madhav Danthala has been featured across national newspapers, regional print media, and television health programs for his expertise in bone marrow transplantation, blood cancers, CAR-T therapy, and comprehensive oncology care in Hyderabad.
Times of India featured a groundbreaking medical achievement by Dr. Madhav Danthala — the first successful matched sibling donor stem cell transplant in Andhra Pradesh. The article highlights how this procedure saved the life of a 20-year-old blood cancer patient, with stem cells donated by his sister who was a perfect match.
AP7am featured Dr. Madhav Danthala and Manipal Hospital Vijayawada's commitment to providing quality and affordable treatments under the Aarogyasri scheme. The article highlights the successful treatment of a 6-year-old child with Primary Refractory Hodgkin Lymphoma through bone marrow transplant.
The New Indian Express reports that Manipal Hospitals recently reached the milestone of completing 50 successful bone marrow transplants, saving lives of both children and adults. Dr. Madhav Danthala discusses the wide range of diseases treated and the outstanding results achieved.
Deccan Chronicle highlights how AP government's Aarogyasri scheme is making bone marrow transplants accessible to patients. Dr. Madhav Danthala explains the wide range of diseases treated and emphasizes the low transplant-related mortality rate achieved through modern technology.
Featured across Telugu and English news channels, Dr. Madhav Danthala shares timely cancer insights, screening advice, and expert perspectives on public health.
Dr. Madhav discusses performing the first haploidentical stem cell transplant in Andhra Pradesh — a historic moment in the state's transplant care.
On TV5's Good Health show, Dr. Madhav explains how to recognize blood cancer symptoms and the importance of timely intervention.
This 10TV episode explores when chemotherapy is appropriate and when bone marrow transplants offer the best outcome for patients.
Dr. Madhav explains the bone marrow transplantation process and what patients can expect, featured on ETV Andhra Pradesh's Sukhibhava program.
Dr. Madhav answers common questions about blood cancer and emphasizes the importance of awareness and early screening.
In this patient-friendly segment, Dr. Madhav discusses symptoms and treatment options for multiple myeloma.
Long-form notes on the questions that matter most when cancer enters your life — screening, second opinions, treatment decisions, family history. Things they don't always tell you in consults, but you need to know.
ASCO 2026 took a hard look at multi-cancer blood tests, BRCA reports, polygenic risk scores, Signatera and Guardant Reveal. What a risk report actually means — and the sequence patients keep getting wrong.
Read article
Toripalimab, tislelizumab, and serplulimab are already in Indian pharmacies. HARMONi-6 at ASCO 2026 and Julie Brahmer's discussant questions — on the slow shift in how the world reads Chinese oncology data.
Read article
A drug for pancreatic cancer at ASCO 2026 moved the survival curve for the first time in fifteen years. The forty-year story behind RASolute 302 — and why honest hope looks like incremental progress.
Read article
A plain-English walkthrough of grade, stage, margins, IHC markers (ER, PR, HER2, Ki-67, PD-L1), and molecular testing — the document every treatment decision is built from.
Read article
Two patients in "complete remission" can have very different prognoses depending on what measurable residual disease testing shows. Plain English on what it is and what your result means.
Read article
For low-risk Gleason 6 disease, watching is one of the most underused, evidence-based strategies in modern oncology. Who's a candidate, what the protocol looks like, fifteen years of data.
Read article
Young-onset colorectal cancer is one of the fastest-growing cancers in Indian metros. The screening age moved for a reason. Who should start earlier, when FIT works, what to expect on the day.
Read article
Three questions to ask family on a Sunday afternoon. The answers can shift your screening calendar by a decade. A practical guide to family history, BRCA, Lynch syndrome.
Read article
More than half of new lung cancer diagnoses in Indian women under fifty are in people who never smoked. Air pollution, EGFR mutations, and the diagnostic delay that costs months.
Read article
More than one defensible plan often exists. A second opinion confirms the path — or surfaces an alternative. When to ask, how to ask, what second opinions actually change.
Read article
Outcomes range from complete cure to relapse or treatment-related complications. Knowing what's typical at day +30, day +100, and the first year helps you prepare for recovery.
Read guide
During the critical first 3–6 months, your immune system is rebuilding. Practical guidelines for pets, work, exercise, and the small daily decisions that protect a smooth recovery.
Read guideFollow Dr. Madhav for regular updates, insights, and patient stories.
